• NEBANNER

Featured

  • Best-Selling Daf Water Treatment - 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone Hydrochloride – JIN DUN

    Best-Selling Daf Water Treatment - 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone Hydrochloride – JIN DUN

    12.The intermediate 4-(4-aminophenyl)-3-morpholinone (1) of the anticoagulant rivaroxaban was prepared by two methods: ①Bromobenzene was successively reacted with ethanolamine and chloroacetyl chloride to obtain 4-benzene The morpholinone is then nitrated to reduce to 1, and the total yield is about 32%; ②Bromobenzene is first nitrated, and then reacted with ethanolamine to obtain 2-(4-nitroanilino)ethanol, which is then closed by chloroacetyl chloride. The reduction reaction produces 1, and ...
  • Chinese Professional Haloperidol For Sleep - Ethyl bromo-difluroacetate – JIN DUN

    Chinese Professional Haloperidol For Sleep - Ethyl bromo-difluroacetate – JIN DUN

    Ethyl bromo-difluroacetate is used as the intermediate of Gemcitabine. Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for use in more than...
  • Personlized Products Plastic And Metal - 1-Bromo-2-methoxy-3-nitro-benzene – JIN DUN

    Personlized Products Plastic And Metal - 1-Bromo-2-methoxy-3-nitro-benzene – JIN DUN

    1-Bromo-2-methoxy-3-nitro-benzene is used as the intermediate of Eltrombopag . Eltrombopag, developed by GlaxoSmithKline (GSK) in the UK and later jointly developed with Novartis in Switzerland, is the first and only approved small molecule non peptide TPO receptor agonist in the world. Eltrombopag was approved by the US FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP), and in 2014 for the treatment of severe aplastic anemia (AA). It is also the first drug approved b...
  • China Supplier Water Treatment Steps - 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]- 5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2 (4h)-one  – JIN DUN

    China Supplier Water Treatment Steps - 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]- 5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2 (4h)-one – JIN DUN

    5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]- 5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2 (4h)-one is used as the intermediate of Prasugrel . Prasugrel is a thiophenopyridine antiplatelet developed by Eli Lilly and daiichisankyo, a Japanese pharmaceutical manufacturer. It is a precursor drug. It forms an active molecule after metabolism through cytochrome P450 in the liver and combines with platelet P2Y12 receptor to exert an active against platelet aggregation. Clinical studies have proved ...
  • Low MOQ for Silicon Curable Resin - (R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid – JIN DUN

    Low MOQ for Silicon Curable Resin - (R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid – JIN DUN

    (R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid is used as the intermediate of Pregabalin. Pregabalin belongs to non γ- GABA receptor agonist or antagonist is a new type of calcium channel regulator, which can block voltage dependent calcium channels and reduce the release of neurotransmitters. Clinically, it is mainly used for neuralgia related to diabetes peripheral neuropathy, post herpetic neuralgia and adjuvant treatment of adult partial seizures, generalized anxiety disorder, central neu...
  • OEM Supply Ion Exchange Water Treatment - 4-(1-piperidino)piperidine; 1,4′-bipiperidine – JIN DUN

    OEM Supply Ion Exchange Water Treatment - 4-(1-piperidino)piperidine; 1,4′-bipiperidine – JIN DUN

    4-(1-piperidino)piperidine; 1,4′-bipiperidine is used as the intermediate of Irinotecan. Irinotecan antitumor drug. It is an inhibitor of DNA synthesis. It is a semi synthetic derivative of camptothecin; Used for preparing irinotecan hydrochloride and irinotecan hydrochloride trihydrate; Large scale clinical trials have shown that irinotecan hydrochloride has obvious inhibitory effects on a variety of tumors, such as colon cancer, small cell lung cancer, rectal cancer and leukemia, and ...
  • Low price for Well Shock Treatment - Ethylmethyl-carbamic chloride – JIN DUN

    Low price for Well Shock Treatment - Ethylmethyl-carbamic chloride – JIN DUN

    Ethylmethyl-carbamic chloride is used as the intermediate of Rivastigmine tartrate . Rivastigmine tartrate is rivastigmine Alzheimer’s disease drugs, rivastigmine is physostigmine derivative by Novartis for the first time successfully developed the trade name Exelon (exelon), a molecule with there carbamate structure, is a kind of amino acid of selective cerebral cholinesterase inhibitor, can also inhibit the acetylcholinesterase and butyrylcholinesterase, cholinergic neurons by delayin...
  • Bottom price Depot Antipsychotics - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN

    Bottom price Depot Antipsychotics - 2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid – JIN DUN

    2′-Methoxy-3′-nitro-biphenyl-3-carboxylic acid is used as the intermediate of Eltrombopag . Eltrombopag, developed by GlaxoSmithKline (GSK) in the UK and later jointly developed with Novartis in Switzerland, is the first and only approved small molecule non peptide TPO receptor agonist in the world. Eltrombopag was approved by the US FDA in 2008 for the treatment of idiopathic thrombocytopenic purpura (ITP), and in 2014 for the treatment of severe aplastic anemia (AA). It is also ...
  • 100% Original Multimodal Anesthesia - 7,10-o-ditroc docetaxel – JIN DUN

    100% Original Multimodal Anesthesia - 7,10-o-ditroc docetaxel – JIN DUN

    7,10-o-ditroc docetaxel is used as the intermediate of Docetaxel Docetaxel is suitable for the treatment of locally advanced or metastatic breast cancer. Docetaxel is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, even after the failure of cisplatin based chemotherapy.
  • Online Exporter Wastewater Treatment Process - 2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate – JIN DUN

    Online Exporter Wastewater Treatment Process - 2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate – JIN DUN

    2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate is used as the intermediate of Gemcitabine . Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been app...
  • Newly Arrival Zuclopenthixol Tablets - 4-Methoxybenzylalkohol;ANISALKOHOL;4-methoxy-benzenemethano; – JIN DUN

    Newly Arrival Zuclopenthixol Tablets - 4-Methoxybenzylalkohol;ANISALKOHOL;4-methoxy-benzenemethano; – JIN DUN

    Intermediate for Moxonidine Can excite central α2 receptors and cause antihypertensive effects, similar to clonidine. The oral absorption rate (90%) and bioavailability (88%) are both high, and there is no first-pass effect. The peak blood concentration appears 1 to 3 hours after taking the drug. Most of it is excreted by the kidneys. t1/2 is about 2 hours. Clinically used for hypertension. Colorless or slightly yellow liquid. The melting point is 23-25.5°C, the boiling point is 159°C, the re...
  • Short Lead Time for Pendant Making - (2-butyl-5-nitro-1-benzofuran-3-yl)-[4-[3-(dibutylamino)propoxy]phenyl]methanone – JIN DUN

    Short Lead Time for Pendant Making - (2-butyl-5-nitro-1-benzofuran-3-yl)-[4-[3-(dibutylamino)propoxy]phenyl]methanone – JIN DUN

    (2-butyl-5-nitro-1-benzofuran-3-yl)-[4-[3-(dibutylamino)propoxy]phenyl]methanone is used as the intermediate of Dronedarone . Dronedarone is an antiarrhythmic drug. It is suitable for patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), reducing the risk of hospitalization, patients with recent AF / AFL attacks and cardiovascular risk factors, and patients with sinus rhythm or cardioversion. About the pharmacological action, pharmacokinetics, drug interacti...